CYP2D6 polymorphisms may predict occurrence of adverse effects to tamoxifen: a preliminary retrospective study

Ishani Wickramage,1 Kamani Hemamala Tennekoon,1 Merenchi Arachchige Yasantha Ariyaratne,2 Asanka Sudeshini Hewage,1 Tharmini Sundralingam,1 1Institute of Biochemistry, Molecular Biology and Biotechnology (IBMBB), University of Colombo, Colombo, Sri Lanka; 2National Cancer Institute, Maharagama, Sri...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wickramage I, Tennekoon KH, Ariyaratne MAY, Hewage AS, Sundralingam T
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2017
Materias:
SNP
Acceso en línea:https://doaj.org/article/2a0a43ca283d402fbdb8713e47f04772
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!